Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours-Reference-Cited by-同舟云学术

Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours

Published:2017-06-06 Issue:1 Volume:5 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Haque Farhana,Varlet Pascale,Puntonet Julien,Storer Lisa,Bountali Aikaterini,Rahman Ruman,Grill Jacques,Carcaboso Angel M,Jones Chris,Layfield Robert,Grundy Richard G

Funder

Billie Butterfly Fund, Brain tumour Charity

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-017-0449-1.pdf

Reference15 articles.

1. Bax DA, Little SE, Gaspar N, Perryman L, Marshall L, Viana-Pereira M, Jones TA, Williams RD, Grigoriadis A, Vassal G, Workman P, Sheer D, Reis RM, ADJ P, Hargrave D, Jones C (2009) Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. PLoS One 4:e5209. doi: 10.1371/journal.pone.0005209

2. Bechet D, Gielen GGH, Korshunov A, Pfister SM, Rousso C, Faury D, Fiset P-O, Benlimane N, Lewis PW, Lu C, David Allis C, Kieran MW, Ligon KL, Pietsch T, Ellezam B, Albrecht S, Jabado N (2014) Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 128:733–741. doi: 10.1007/s00401-014-1337-4

3. Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DTW, Kool M, Zapatka M, Northcott PA, Sturm D, Wang W, Radlwimmer B, Højfeldt JW, Truffaux N, Castel D, Schubert S, Ryzhova M, Seker-Cin H, Gronych J, Johann PD, Stark S, Meyer J, Milde T, Schuhmann M, Ebinger M, Monoranu C-M, Ponnuswami A, Chen S, Jones C, Witt O, Collins VP, von Deimling A, Jabado N, Puget S, Grill J, Helin K, Korshunov A, Lichter P, Monje M, Plass C, Cho Y-J, Pfister SM (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24:660–672. doi: 10.1016/j.ccr.2013.10.006

4. Bjerke L, Mackay A, Nandhabalan M, Burford A, Jury A, Popov S, Bax DA, Carvalho D, Taylor KR, Vinci M, Bajrami I, IM MG, Lord CJ, Reis RM, Hargrave D, Ashworth A, Workman P, Jones C (2013) Histone H3.3 mutations drive pediatric Glioblastoma through Upregulation of MYCN. Cancer Discov 3:512–519. doi: 10.1158/2159-8290.CD-12-0426

5. Chan K-M, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R, Sarkaria J, Zhang Z (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes dev 27:985–990. doi: 10.1101/gad.217778.113

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options;Biomedicines;2023-07-15

2. Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5;International Journal of General Medicine;2023-01

3. Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review;Oncology;2023

4. Pathology of the Tumors of the Central Nervous System;Intraoperative Flow Cytometry;2023

5. Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry;Frontiers in Oncology;2022-12-08